Normalized creatinine-to-cystatin C ratio and cardiovascular disease risk in populations with cardiovascular–kidney–metabolic syndrome stages 0–3: findings from a national and prospective cohort study
The baseline NCCR exhibits an inverse correlation with the risk of CVD in individuals diagnosed with cardiovascular-kidney-metabolic (CKM) syndrome at stages 0 to 3. Consequently, it may serve as a valuable biomarker for assessing CVD risk in this population.
Authors
- Lining Yang (ORCID: https://orcid.org/0000-0002-3276-8589)
- Lei Tang (ORCID: https://orcid.org/0000-0002-2808-5187)
- Qiuyi Lu (ORCID: https://orcid.org/0009-0003-9129-0954)
- Defei Chen
- Fu Song
- Weilin Tan
- Dingqun Bai
- Zheng Yang
- Tailin Ran
- Yuhui Li
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1186/s40001-026-03905-z
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00